Into 2030: What Adjustments Has the Global Pandemic Made to the Government Program for the Next Decade?
- Outcomes of the Pharma-2020 program: challenges and results
- Program “Pharma-2030”: priorities, main directions, challenges, and concerns
- Manufacturing of pharmaceutical substances: how to reduce dependence on supplies from Asia?
- Priorities in the development of innovative drugs and generics production
- Cooperation with international companies in the framework of the localisation of drug production projects
- Export potential of the Russian pharmaceutical industry: drug groups and markets
Wednesday, 28 April
- 10:00 - 11:00
- Into 2030: What Adjustments Has the Global Pandemic Made to the Government Program for the Next Decade?